 Makoto Miyazaki
Concepts (510)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Stearoyl-CoA Desaturase | 42 | 2015 | 62 | 4.840 |
Why?
| | Vascular Calcification | 9 | 2022 | 107 | 4.220 |
Why?
| | Renal Insufficiency, Chronic | 9 | 2024 | 564 | 2.500 |
Why?
| | Endoplasmic Reticulum | 6 | 2025 | 260 | 1.850 |
Why?
| | Receptors, Cytoplasmic and Nuclear | 9 | 2018 | 215 | 1.770 |
Why?
| | Activating Transcription Factor 4 | 5 | 2021 | 20 | 1.710 |
Why?
| | Atherosclerosis | 8 | 2021 | 405 | 1.700 |
Why?
| | Transcription Factor CHOP | 4 | 2018 | 30 | 1.600 |
Why?
| | Bile Acids and Salts | 3 | 2018 | 195 | 1.460 |
Why?
| | Autophagy | 6 | 2025 | 266 | 1.450 |
Why?
| | Fatty Acids | 19 | 2018 | 413 | 1.300 |
Why?
| | Liver | 21 | 2019 | 1827 | 1.250 |
Why?
| | Endoplasmic Reticulum Stress | 4 | 2021 | 101 | 1.210 |
Why?
| | Calcinosis | 4 | 2014 | 231 | 1.080 |
Why?
| | Membrane Proteins | 4 | 2025 | 1108 | 1.070 |
Why?
| | Mice | 71 | 2025 | 16579 | 1.050 |
Why?
| | Lipids | 11 | 2018 | 624 | 1.040 |
Why?
| | Receptors, G-Protein-Coupled | 2 | 2018 | 206 | 0.930 |
Why?
| | Animals | 79 | 2025 | 34501 | 0.820 |
Why?
| | Deoxycholic Acid | 3 | 2022 | 13 | 0.810 |
Why?
| | Hyperphosphatemia | 1 | 2022 | 15 | 0.790 |
Why?
| | Leptin | 9 | 2010 | 218 | 0.780 |
Why?
| | Stearic Acids | 2 | 2012 | 14 | 0.770 |
Why?
| | Mice, Knockout | 28 | 2025 | 2752 | 0.730 |
Why?
| | Intracellular Signaling Peptides and Proteins | 2 | 2025 | 425 | 0.710 |
Why?
| | Myocytes, Smooth Muscle | 3 | 2018 | 245 | 0.680 |
Why?
| | Kidney | 9 | 2024 | 1305 | 0.670 |
Why?
| | Vascular Diseases | 2 | 2014 | 236 | 0.650 |
Why?
| | Starvation | 1 | 2019 | 22 | 0.640 |
Why?
| | Isoenzymes | 6 | 2006 | 304 | 0.630 |
Why?
| | Lipid Metabolism | 15 | 2018 | 493 | 0.630 |
Why?
| | Cyclin T | 1 | 2018 | 2 | 0.620 |
Why?
| | Cyclin-Dependent Kinase 9 | 1 | 2018 | 10 | 0.620 |
Why?
| | Vascular Stiffness | 1 | 2024 | 476 | 0.610 |
Why?
| | Kidney Diseases | 4 | 2019 | 368 | 0.560 |
Why?
| | Mice, Inbred C57BL | 24 | 2025 | 5257 | 0.560 |
Why?
| | Apolipoproteins E | 4 | 2014 | 78 | 0.550 |
Why?
| | Coronary Vessels | 2 | 2022 | 235 | 0.540 |
Why?
| | eIF-2 Kinase | 2 | 2013 | 28 | 0.530 |
Why?
| | Cholesterol | 8 | 2016 | 406 | 0.530 |
Why?
| | Lipogenesis | 4 | 2012 | 59 | 0.520 |
Why?
| | Phosphatidylethanolamines | 1 | 2015 | 74 | 0.490 |
Why?
| | Coronary Artery Disease | 2 | 2022 | 677 | 0.480 |
Why?
| | Triglycerides | 11 | 2014 | 524 | 0.480 |
Why?
| | Osteogenesis | 4 | 2021 | 178 | 0.450 |
Why?
| | Fatty Acid Desaturases | 2 | 2006 | 32 | 0.450 |
Why?
| | CCAAT-Enhancer-Binding Proteins | 5 | 2020 | 37 | 0.430 |
Why?
| | Signal Transduction | 14 | 2024 | 4829 | 0.420 |
Why?
| | Dietary Fats | 5 | 2007 | 301 | 0.410 |
Why?
| | Metabolomics | 1 | 2018 | 597 | 0.410 |
Why?
| | Blood Vessels | 2 | 2011 | 184 | 0.410 |
Why?
| | Disease Models, Animal | 13 | 2024 | 3943 | 0.390 |
Why?
| | CCAAT-Enhancer-Binding Protein-beta | 3 | 2019 | 31 | 0.390 |
Why?
| | Muscle, Smooth, Vascular | 3 | 2024 | 417 | 0.380 |
Why?
| | Cisplatin | 3 | 2020 | 297 | 0.360 |
Why?
| | Transcription Factors | 6 | 2006 | 1631 | 0.350 |
Why?
| | Cells, Cultured | 11 | 2019 | 4008 | 0.350 |
Why?
| | Gene Expression Regulation | 7 | 2020 | 2506 | 0.340 |
Why?
| | Fatty Liver | 3 | 2012 | 232 | 0.340 |
Why?
| | DNA-Binding Proteins | 7 | 2008 | 1415 | 0.320 |
Why?
| | Acute Kidney Injury | 3 | 2025 | 774 | 0.320 |
Why?
| | Inflammation | 6 | 2021 | 2664 | 0.310 |
Why?
| | Sterol Regulatory Element Binding Protein 1 | 9 | 2011 | 57 | 0.310 |
Why?
| | Mice, Transgenic | 7 | 2018 | 2069 | 0.300 |
Why?
| | Cardiovascular Diseases | 2 | 2018 | 2018 | 0.300 |
Why?
| | Polycystic Kidney, Autosomal Dominant | 2 | 2024 | 223 | 0.300 |
Why?
| | Tumor Necrosis Factor-alpha | 1 | 2013 | 1190 | 0.300 |
Why?
| | Protein Isoforms | 5 | 2019 | 375 | 0.300 |
Why?
| | Male | 38 | 2025 | 62883 | 0.290 |
Why?
| | Phosphorylation | 8 | 2018 | 1681 | 0.290 |
Why?
| | Macrophages | 6 | 2021 | 1463 | 0.290 |
Why?
| | Orphan Nuclear Receptors | 5 | 2012 | 15 | 0.290 |
Why?
| | Adiposity | 3 | 2010 | 505 | 0.290 |
Why?
| | Oleic Acid | 4 | 2009 | 39 | 0.290 |
Why?
| | Mice, Inbred DBA | 2 | 2018 | 182 | 0.280 |
Why?
| | Cell Proliferation | 4 | 2024 | 2335 | 0.270 |
Why?
| | AMP-Activated Protein Kinases | 5 | 2022 | 190 | 0.270 |
Why?
| | Myocardium | 4 | 2010 | 970 | 0.260 |
Why?
| | Obesity | 8 | 2010 | 2860 | 0.250 |
Why?
| | Transcription, Genetic | 4 | 2020 | 1398 | 0.250 |
Why?
| | Humans | 37 | 2025 | 128524 | 0.250 |
Why?
| | Receptors, LDL | 2 | 2018 | 45 | 0.250 |
Why?
| | Insulin Resistance | 3 | 2009 | 1166 | 0.250 |
Why?
| | Fructokinases | 2 | 2016 | 31 | 0.240 |
Why?
| | Adipose Tissue | 4 | 2010 | 591 | 0.230 |
Why?
| | Uric Acid | 2 | 2024 | 161 | 0.230 |
Why?
| | Salmonella Infections | 1 | 2025 | 52 | 0.230 |
Why?
| | Deoxyglucose | 1 | 2024 | 49 | 0.230 |
Why?
| | Urate Oxidase | 1 | 2024 | 11 | 0.230 |
Why?
| | Epithelial Cells | 3 | 2019 | 1036 | 0.220 |
Why?
| | Energy Metabolism | 3 | 2008 | 836 | 0.220 |
Why?
| | Cell Line | 5 | 2018 | 2731 | 0.220 |
Why?
| | Diet | 4 | 2021 | 1200 | 0.220 |
Why?
| | Glomerulonephritis | 2 | 2021 | 47 | 0.220 |
Why?
| | Fructose | 1 | 2004 | 107 | 0.220 |
Why?
| | Salmonella typhimurium | 1 | 2025 | 176 | 0.210 |
Why?
| | Polycystic Kidney Diseases | 1 | 2024 | 63 | 0.210 |
Why?
| | Liver X Receptors | 5 | 2012 | 30 | 0.210 |
Why?
| | Sebaceous Glands | 1 | 2002 | 5 | 0.210 |
Why?
| | Kidney Tubules, Proximal | 2 | 2022 | 125 | 0.210 |
Why?
| | TOR Serine-Threonine Kinases | 2 | 2024 | 380 | 0.210 |
Why?
| | Fatty Acids, Unsaturated | 4 | 2005 | 95 | 0.210 |
Why?
| | Isothiocyanates | 1 | 2022 | 2 | 0.200 |
Why?
| | Gene Expression Regulation, Enzymologic | 3 | 2012 | 283 | 0.200 |
Why?
| | Autophagy-Related Protein-1 Homolog | 1 | 2022 | 7 | 0.200 |
Why?
| | Sodium-Phosphate Cotransporter Proteins, Type IIa | 1 | 2022 | 9 | 0.200 |
Why?
| | Lysosomes | 2 | 2021 | 136 | 0.200 |
Why?
| | Biomarkers | 5 | 2025 | 3881 | 0.200 |
Why?
| | Folate Receptor 2 | 1 | 2021 | 9 | 0.190 |
Why?
| | Multienzyme Complexes | 4 | 2005 | 69 | 0.190 |
Why?
| | Parathyroid Hormone | 1 | 2022 | 106 | 0.190 |
Why?
| | Phosphates | 1 | 2022 | 167 | 0.180 |
Why?
| | Toxins, Biological | 1 | 2020 | 11 | 0.180 |
Why?
| | Kidney Glomerulus | 2 | 2019 | 106 | 0.180 |
Why?
| | Fibroblast Growth Factors | 1 | 2022 | 171 | 0.180 |
Why?
| | Anticholesteremic Agents | 2 | 2012 | 146 | 0.180 |
Why?
| | Spectrum Analysis, Raman | 2 | 2011 | 41 | 0.180 |
Why?
| | Skin | 1 | 2005 | 717 | 0.170 |
Why?
| | Homeostasis | 2 | 2021 | 605 | 0.170 |
Why?
| | Podocytes | 2 | 2019 | 51 | 0.170 |
Why?
| | Amino Acid Sequence | 3 | 2019 | 2041 | 0.170 |
Why?
| | Sodium-Phosphate Cotransporter Proteins, Type IIb | 1 | 2020 | 9 | 0.170 |
Why?
| | Tissue Distribution | 3 | 2007 | 290 | 0.170 |
Why?
| | NF-kappa B | 1 | 2024 | 651 | 0.170 |
Why?
| | Gene Knockout Techniques | 2 | 2018 | 109 | 0.170 |
Why?
| | Down-Regulation | 4 | 2008 | 629 | 0.170 |
Why?
| | Cattle | 3 | 2011 | 962 | 0.160 |
Why?
| | Mitogen-Activated Protein Kinase Kinases | 1 | 2020 | 129 | 0.160 |
Why?
| | Insulin | 7 | 2009 | 2318 | 0.160 |
Why?
| | Kidney Failure, Chronic | 1 | 2025 | 535 | 0.160 |
Why?
| | Hepatocytes | 2 | 2019 | 213 | 0.160 |
Why?
| | HeLa Cells | 5 | 2025 | 603 | 0.160 |
Why?
| | Tretinoin | 1 | 2020 | 124 | 0.160 |
Why?
| | Amino Acids | 2 | 2021 | 474 | 0.160 |
Why?
| | Bacterial Proteins | 1 | 2025 | 826 | 0.160 |
Why?
| | Fatty Acids, Monounsaturated | 4 | 2009 | 51 | 0.160 |
Why?
| | Sepsis | 1 | 2025 | 556 | 0.160 |
Why?
| | Blotting, Northern | 6 | 2005 | 199 | 0.160 |
Why?
| | Intestine, Small | 1 | 2020 | 141 | 0.160 |
Why?
| | Heat-Shock Response | 1 | 2019 | 71 | 0.160 |
Why?
| | Mitochondria, Liver | 2 | 2012 | 73 | 0.150 |
Why?
| | Renal Insufficiency | 1 | 2021 | 148 | 0.150 |
Why?
| | Receptors, Fc | 1 | 2019 | 52 | 0.150 |
Why?
| | Carrier Proteins | 2 | 2021 | 731 | 0.150 |
Why?
| | Osteopontin | 1 | 2018 | 30 | 0.150 |
Why?
| | Serum Albumin | 1 | 2019 | 145 | 0.150 |
Why?
| | Hypoxia-Inducible Factor 1 | 1 | 2018 | 69 | 0.150 |
Why?
| | TRPP Cation Channels | 3 | 2024 | 74 | 0.150 |
Why?
| | Fever | 1 | 2019 | 301 | 0.140 |
Why?
| | Chemical and Drug Induced Liver Injury | 1 | 2019 | 134 | 0.140 |
Why?
| | Dietary Carbohydrates | 3 | 2007 | 152 | 0.140 |
Why?
| | Histocompatibility Antigens Class I | 1 | 2019 | 195 | 0.140 |
Why?
| | Interleukin-33 | 1 | 2017 | 49 | 0.140 |
Why?
| | Disease Progression | 3 | 2021 | 2603 | 0.140 |
Why?
| | Adaptive Immunity | 1 | 2018 | 159 | 0.140 |
Why?
| | Chelating Agents | 1 | 2017 | 67 | 0.140 |
Why?
| | Gene Knockdown Techniques | 3 | 2014 | 311 | 0.140 |
Why?
| | Ion Pumps | 1 | 2016 | 1 | 0.140 |
Why?
| | Phosphorus | 1 | 2017 | 93 | 0.140 |
Why?
| | Hypertriglyceridemia | 3 | 2008 | 39 | 0.130 |
Why?
| | Mice, Mutant Strains | 4 | 2012 | 292 | 0.130 |
Why?
| | Protein Structure, Tertiary | 3 | 2011 | 836 | 0.130 |
Why?
| | Adipocytes, White | 2 | 2022 | 17 | 0.130 |
Why?
| | Adaptor Proteins, Signal Transducing | 1 | 2019 | 391 | 0.130 |
Why?
| | Heart | 4 | 2010 | 638 | 0.130 |
Why?
| | Cell Differentiation | 4 | 2012 | 1883 | 0.130 |
Why?
| | Mitochondria | 3 | 2019 | 844 | 0.130 |
Why?
| | Base Sequence | 4 | 2007 | 2134 | 0.130 |
Why?
| | Muscle, Smooth | 1 | 2016 | 145 | 0.130 |
Why?
| | Carbohydrate Metabolism | 2 | 2007 | 60 | 0.120 |
Why?
| | Chromatography, Liquid | 1 | 2017 | 374 | 0.120 |
Why?
| | Diet, Fat-Restricted | 2 | 2006 | 79 | 0.120 |
Why?
| | Gene Expression Profiling | 4 | 2019 | 1687 | 0.120 |
Why?
| | Rats | 5 | 2024 | 5168 | 0.120 |
Why?
| | Promoter Regions, Genetic | 1 | 2020 | 1199 | 0.120 |
Why?
| | Nitric Oxide Synthase Type III | 2 | 2016 | 201 | 0.120 |
Why?
| | Albuminuria | 1 | 2016 | 181 | 0.120 |
Why?
| | Cell Cycle Proteins | 1 | 2019 | 580 | 0.120 |
Why?
| | Hydrocarbons, Fluorinated | 2 | 2012 | 9 | 0.120 |
Why?
| | Tetraspanins | 1 | 2014 | 15 | 0.120 |
Why?
| | Protein Binding | 3 | 2018 | 2097 | 0.120 |
Why?
| | Female | 22 | 2025 | 68127 | 0.120 |
Why?
| | Metabolic Syndrome | 3 | 2008 | 340 | 0.120 |
Why?
| | Neoplasms, Glandular and Epithelial | 1 | 2014 | 35 | 0.120 |
Why?
| | Ketocholesterols | 1 | 2014 | 7 | 0.120 |
Why?
| | Immunoglobulin G | 1 | 2019 | 837 | 0.120 |
Why?
| | Bone Marrow | 1 | 2016 | 267 | 0.120 |
Why?
| | Osteoblasts | 2 | 2012 | 126 | 0.110 |
Why?
| | Ezetimibe | 1 | 2014 | 26 | 0.110 |
Why?
| | Azetidines | 1 | 2014 | 40 | 0.110 |
Why?
| | Simvastatin | 1 | 2014 | 55 | 0.110 |
Why?
| | Protein Kinase Inhibitors | 1 | 2020 | 872 | 0.110 |
Why?
| | Body Weight | 7 | 2010 | 931 | 0.110 |
Why?
| | Dehydration | 1 | 2013 | 50 | 0.110 |
Why?
| | Bone Density | 1 | 2017 | 476 | 0.110 |
Why?
| | Sensitivity and Specificity | 1 | 2018 | 1820 | 0.110 |
Why?
| | Gastrointestinal Microbiome | 1 | 2020 | 635 | 0.100 |
Why?
| | Cholesterol Ester Transfer Proteins | 1 | 2012 | 18 | 0.100 |
Why?
| | Muscle, Skeletal | 5 | 2005 | 1639 | 0.100 |
Why?
| | Benzoates | 1 | 2012 | 40 | 0.100 |
Why?
| | CD8-Positive T-Lymphocytes | 1 | 2018 | 840 | 0.100 |
Why?
| | Isoxazoles | 1 | 2012 | 54 | 0.100 |
Why?
| | Catechin | 1 | 2012 | 26 | 0.100 |
Why?
| | Nicorandil | 1 | 2012 | 10 | 0.100 |
Why?
| | Lipoproteins, HDL | 1 | 2012 | 85 | 0.100 |
Why?
| | Minerals | 1 | 2012 | 39 | 0.100 |
Why?
| | Nitric Oxide Donors | 1 | 2012 | 18 | 0.100 |
Why?
| | Middle Aged | 6 | 2025 | 30893 | 0.100 |
Why?
| | Case-Control Studies | 3 | 2017 | 3326 | 0.100 |
Why?
| | RNA, Messenger | 7 | 2018 | 2674 | 0.100 |
Why?
| | DNA Primers | 3 | 2007 | 510 | 0.100 |
Why?
| | Oxidation-Reduction | 5 | 2010 | 1001 | 0.100 |
Why?
| | Biomedical Research | 1 | 2018 | 646 | 0.100 |
Why?
| | Mitochondrial Diseases | 1 | 2012 | 89 | 0.090 |
Why?
| | Antioxidants | 2 | 2012 | 543 | 0.090 |
Why?
| | Acetyl-CoA Carboxylase | 1 | 2011 | 33 | 0.090 |
Why?
| | Molecular Imaging | 1 | 2011 | 55 | 0.090 |
Why?
| | Drug Therapy, Combination | 1 | 2014 | 1009 | 0.090 |
Why?
| | Models, Biological | 5 | 2006 | 1693 | 0.090 |
Why?
| | Aorta | 2 | 2012 | 407 | 0.090 |
Why?
| | Risk Factors | 3 | 2022 | 9727 | 0.090 |
Why?
| | Sulfonamides | 2 | 2012 | 500 | 0.090 |
Why?
| | Etoposide | 1 | 2011 | 149 | 0.090 |
Why?
| | Plaque, Atherosclerotic | 1 | 2011 | 55 | 0.090 |
Why?
| | Glucose | 2 | 2007 | 983 | 0.090 |
Why?
| | Alkaline Phosphatase | 1 | 2011 | 142 | 0.090 |
Why?
| | Chenodeoxycholic Acid | 1 | 2010 | 14 | 0.090 |
Why?
| | Cholesterol, HDL | 2 | 2012 | 203 | 0.090 |
Why?
| | Reproducibility of Results | 1 | 2018 | 3023 | 0.090 |
Why?
| | Antineoplastic Agents | 2 | 2020 | 2058 | 0.080 |
Why?
| | Aging | 2 | 2019 | 1770 | 0.080 |
Why?
| | Mice, Obese | 3 | 2006 | 57 | 0.080 |
Why?
| | Diacylglycerol O-Acyltransferase | 2 | 2006 | 3 | 0.080 |
Why?
| | Fibroblasts | 1 | 2014 | 939 | 0.080 |
Why?
| | Agouti Signaling Protein | 1 | 2009 | 3 | 0.080 |
Why?
| | Cholic Acids | 1 | 2008 | 17 | 0.080 |
Why?
| | Aged | 4 | 2025 | 21971 | 0.080 |
Why?
| | Gene Silencing | 2 | 2016 | 185 | 0.080 |
Why?
| | Microscopy | 1 | 2010 | 140 | 0.080 |
Why?
| | Hypercholesterolemia | 2 | 2006 | 101 | 0.080 |
Why?
| | Ceramides | 2 | 2010 | 104 | 0.080 |
Why?
| | Lung Neoplasms | 2 | 2020 | 2323 | 0.080 |
Why?
| | Hyperlipidemia, Familial Combined | 1 | 2008 | 3 | 0.080 |
Why?
| | Diabetic Nephropathies | 1 | 2012 | 277 | 0.070 |
Why?
| | Transgenes | 2 | 2006 | 177 | 0.070 |
Why?
| | Lipocalin-2 | 2 | 2020 | 76 | 0.070 |
Why?
| | Receptor, Insulin | 2 | 2006 | 100 | 0.070 |
Why?
| | Phosphatidylcholines | 2 | 2008 | 146 | 0.070 |
Why?
| | Blotting, Western | 6 | 2007 | 1168 | 0.070 |
Why?
| | Acyltransferases | 2 | 2005 | 51 | 0.070 |
Why?
| | Microsomes | 2 | 2007 | 29 | 0.070 |
Why?
| | Tumor Burden | 2 | 2020 | 282 | 0.070 |
Why?
| | Time Factors | 4 | 2019 | 6503 | 0.070 |
Why?
| | Glycogen | 2 | 2004 | 55 | 0.070 |
Why?
| | Mycological Typing Techniques | 1 | 2007 | 1 | 0.070 |
Why?
| | Glucose Tolerance Test | 1 | 2009 | 356 | 0.070 |
Why?
| | Gluconeogenesis | 1 | 2007 | 73 | 0.070 |
Why?
| | Adipose Tissue, Brown | 2 | 2004 | 50 | 0.070 |
Why?
| | Histoplasma | 1 | 2007 | 12 | 0.070 |
Why?
| | Histoplasmosis | 1 | 2007 | 14 | 0.070 |
Why?
| | Sucrose | 1 | 2007 | 95 | 0.070 |
Why?
| | Animal Feed | 2 | 2004 | 52 | 0.070 |
Why?
| | Pedigree | 1 | 2008 | 485 | 0.070 |
Why?
| | Mice, SCID | 2 | 2004 | 345 | 0.060 |
Why?
| | Blood Pressure | 4 | 2016 | 1733 | 0.060 |
Why?
| | Mutation | 5 | 2018 | 3692 | 0.060 |
Why?
| | Lipolysis | 2 | 2022 | 40 | 0.060 |
Why?
| | Choline-Phosphate Cytidylyltransferase | 1 | 2005 | 3 | 0.060 |
Why?
| | Molecular Sequence Data | 3 | 2006 | 2818 | 0.060 |
Why?
| | Carnitine O-Palmitoyltransferase | 4 | 2007 | 45 | 0.060 |
Why?
| | Colitis | 1 | 2008 | 240 | 0.060 |
Why?
| | Receptors, Retinoic Acid | 2 | 2020 | 51 | 0.060 |
Why?
| | Palmitoyl Coenzyme A | 1 | 2004 | 2 | 0.060 |
Why?
| | Structure-Activity Relationship | 2 | 2018 | 530 | 0.060 |
Why?
| | Oxypurinol | 1 | 2024 | 3 | 0.060 |
Why?
| | Oxonic Acid | 1 | 2024 | 5 | 0.060 |
Why?
| | Up-Regulation | 2 | 2004 | 826 | 0.060 |
Why?
| | Lipodystrophy | 1 | 2004 | 13 | 0.060 |
Why?
| | Thermogenesis | 1 | 2004 | 44 | 0.060 |
Why?
| | Rats, Sprague-Dawley | 2 | 2024 | 2245 | 0.060 |
Why?
| | Hypothermia | 1 | 2004 | 35 | 0.060 |
Why?
| | Linoleic Acid | 1 | 2004 | 40 | 0.060 |
Why?
| | Xanthine Oxidase | 1 | 2024 | 78 | 0.060 |
Why?
| | Chronic Disease | 1 | 2010 | 1701 | 0.060 |
Why?
| | Severity of Illness Index | 1 | 2012 | 2736 | 0.050 |
Why?
| | Cholestasis | 1 | 2006 | 230 | 0.050 |
Why?
| | Animal Nutritional Physiological Phenomena | 1 | 2003 | 14 | 0.050 |
Why?
| | Anti-Obesity Agents | 1 | 2004 | 53 | 0.050 |
Why?
| | Body Temperature Regulation | 1 | 2004 | 99 | 0.050 |
Why?
| | Cold Temperature | 1 | 2004 | 151 | 0.050 |
Why?
| | Foam Cells | 2 | 2016 | 15 | 0.050 |
Why?
| | Culture Media, Conditioned | 2 | 2016 | 108 | 0.050 |
Why?
| | Animals, Newborn | 1 | 2005 | 805 | 0.050 |
Why?
| | Chromatography, Gas | 1 | 2002 | 31 | 0.050 |
Why?
| | Cell Membrane | 2 | 2005 | 722 | 0.050 |
Why?
| | DNA, Complementary | 1 | 2003 | 267 | 0.050 |
Why?
| | Cholesterol, Dietary | 1 | 2002 | 18 | 0.050 |
Why?
| | Inflammasomes | 1 | 2024 | 128 | 0.050 |
Why?
| | Sequence Homology, Amino Acid | 1 | 2003 | 368 | 0.050 |
Why?
| | Cytokines | 2 | 2024 | 1985 | 0.050 |
Why?
| | Sulfoxides | 1 | 2022 | 3 | 0.050 |
Why?
| | Protein Tyrosine Phosphatases | 1 | 2003 | 160 | 0.050 |
Why?
| | 3T3-L1 Cells | 1 | 2022 | 34 | 0.050 |
Why?
| | Protein Transport | 2 | 2019 | 422 | 0.050 |
Why?
| | Dehydroepiandrosterone | 1 | 2002 | 51 | 0.050 |
Why?
| | Aminopterin | 1 | 2021 | 2 | 0.050 |
Why?
| | Host-Pathogen Interactions | 1 | 2025 | 348 | 0.050 |
Why?
| | Muscle Proteins | 1 | 2003 | 228 | 0.050 |
Why?
| | Saccharomyces cerevisiae | 1 | 2006 | 522 | 0.050 |
Why?
| | RNA | 2 | 2007 | 881 | 0.050 |
Why?
| | Apoptosis | 3 | 2020 | 2437 | 0.050 |
Why?
| | Phospholipids | 1 | 2003 | 209 | 0.050 |
Why?
| | Autophagosomes | 1 | 2021 | 19 | 0.050 |
Why?
| | Autophagy-Related Proteins | 1 | 2021 | 41 | 0.040 |
Why?
| | Japan | 1 | 2021 | 98 | 0.040 |
Why?
| | Enzyme Activation | 3 | 2011 | 799 | 0.040 |
Why?
| | Proteinuria | 1 | 2021 | 87 | 0.040 |
Why?
| | Enzyme Inhibitors | 1 | 2024 | 811 | 0.040 |
Why?
| | Adipocytes | 1 | 2002 | 204 | 0.040 |
Why?
| | Gene Expression Regulation, Developmental | 1 | 2005 | 815 | 0.040 |
Why?
| | Biological Assay | 1 | 2021 | 118 | 0.040 |
Why?
| | Models, Genetic | 1 | 2003 | 590 | 0.040 |
Why?
| | Hypophosphatemia, Familial | 1 | 2020 | 3 | 0.040 |
Why?
| | Blood Urea Nitrogen | 1 | 2020 | 53 | 0.040 |
Why?
| | Butadienes | 1 | 2020 | 35 | 0.040 |
Why?
| | Folic Acid | 1 | 2021 | 183 | 0.040 |
Why?
| | Retinoid X Receptors | 1 | 2020 | 40 | 0.040 |
Why?
| | Methotrexate | 1 | 2021 | 249 | 0.040 |
Why?
| | Immunoblotting | 3 | 2005 | 300 | 0.040 |
Why?
| | 2,4-Dinitrophenol | 1 | 2019 | 8 | 0.040 |
Why?
| | NIH 3T3 Cells | 1 | 2020 | 141 | 0.040 |
Why?
| | Vegetables | 1 | 2021 | 147 | 0.040 |
Why?
| | Kidney Medulla | 1 | 2019 | 32 | 0.040 |
Why?
| | Nitriles | 1 | 2020 | 160 | 0.040 |
Why?
| | Oxygen | 1 | 2004 | 901 | 0.040 |
Why?
| | Reactive Oxygen Species | 2 | 2012 | 579 | 0.040 |
Why?
| | Pyrimidinones | 1 | 2020 | 102 | 0.040 |
Why?
| | Liver Regeneration | 1 | 2019 | 39 | 0.040 |
Why?
| | HSP70 Heat-Shock Proteins | 1 | 2019 | 67 | 0.040 |
Why?
| | Cell Self Renewal | 1 | 2019 | 54 | 0.040 |
Why?
| | Testosterone | 1 | 2002 | 378 | 0.040 |
Why?
| | Rats, Wistar | 1 | 2020 | 398 | 0.040 |
Why?
| | Health Surveys | 1 | 2021 | 492 | 0.040 |
Why?
| | Fibrosis | 1 | 2021 | 522 | 0.040 |
Why?
| | DNA | 1 | 2005 | 1392 | 0.040 |
Why?
| | Pyridones | 1 | 2020 | 159 | 0.040 |
Why?
| | MAP Kinase Signaling System | 1 | 2020 | 302 | 0.040 |
Why?
| | Odds Ratio | 1 | 2021 | 1022 | 0.040 |
Why?
| | Urinary Tract | 1 | 2018 | 37 | 0.040 |
Why?
| | Stem Cells | 1 | 2002 | 578 | 0.040 |
Why?
| | In Vitro Techniques | 2 | 2012 | 1043 | 0.040 |
Why?
| | Glomerular Filtration Rate | 1 | 2021 | 681 | 0.030 |
Why?
| | Weight Loss | 1 | 2002 | 723 | 0.030 |
Why?
| | Neoplasm Proteins | 1 | 2020 | 421 | 0.030 |
Why?
| | Single-Cell Analysis | 1 | 2019 | 274 | 0.030 |
Why?
| | Mice, Knockout, ApoE | 1 | 2016 | 11 | 0.030 |
Why?
| | Antineoplastic Agents, Immunological | 1 | 2018 | 173 | 0.030 |
Why?
| | Dietary Fats, Unsaturated | 2 | 2006 | 23 | 0.030 |
Why?
| | RAW 264.7 Cells | 1 | 2016 | 49 | 0.030 |
Why?
| | Oxidative Stress | 2 | 2012 | 1188 | 0.030 |
Why?
| | Pyridines | 1 | 2019 | 469 | 0.030 |
Why?
| | Hyperlipidemias | 1 | 2016 | 126 | 0.030 |
Why?
| | Chemokine CXCL6 | 1 | 2014 | 2 | 0.030 |
Why?
| | Mice, Inbred Strains | 2 | 2006 | 402 | 0.030 |
Why?
| | Bone Marrow Cells | 1 | 2016 | 294 | 0.030 |
Why?
| | Hematopoiesis | 1 | 2016 | 185 | 0.030 |
Why?
| | Cohort Studies | 1 | 2025 | 5369 | 0.030 |
Why?
| | Blood Glucose | 4 | 2006 | 2092 | 0.030 |
Why?
| | Creatinine | 1 | 2016 | 475 | 0.030 |
Why?
| | Gene Expression | 3 | 2004 | 1462 | 0.030 |
Why?
| | Fatty Acid Synthases | 2 | 2005 | 24 | 0.030 |
Why?
| | Kidney Cortex | 1 | 2013 | 25 | 0.030 |
Why?
| | Incidence | 1 | 2021 | 2619 | 0.030 |
Why?
| | Immunotherapy | 1 | 2018 | 585 | 0.030 |
Why?
| | Dose-Response Relationship, Drug | 1 | 2018 | 1943 | 0.030 |
Why?
| | Aldehyde Reductase | 1 | 2013 | 27 | 0.030 |
Why?
| | Neoplasm Invasiveness | 1 | 2014 | 480 | 0.030 |
Why?
| | Mice, Nude | 1 | 2014 | 682 | 0.030 |
Why?
| | beta Catenin | 1 | 2014 | 219 | 0.030 |
Why?
| | Pregnancy | 1 | 2005 | 6297 | 0.030 |
Why?
| | Lipoproteins, VLDL | 2 | 2002 | 22 | 0.030 |
Why?
| | Macaca fascicularis | 1 | 2012 | 47 | 0.030 |
Why?
| | Cytochromes c | 1 | 2012 | 61 | 0.030 |
Why?
| | Succinate Dehydrogenase | 1 | 2012 | 43 | 0.020 |
Why?
| | Streptozocin | 1 | 2012 | 16 | 0.020 |
Why?
| | Cardiac Surgical Procedures | 1 | 2017 | 492 | 0.020 |
Why?
| | Cholesterol Esters | 1 | 2011 | 7 | 0.020 |
Why?
| | Mice, Inbred BALB C | 1 | 2014 | 1229 | 0.020 |
Why?
| | Bone Matrix | 1 | 2011 | 6 | 0.020 |
Why?
| | Calcification, Physiologic | 1 | 2011 | 34 | 0.020 |
Why?
| | Biological Transport | 1 | 2012 | 394 | 0.020 |
Why?
| | Serum | 1 | 2011 | 56 | 0.020 |
Why?
| | Species Specificity | 1 | 2012 | 567 | 0.020 |
Why?
| | Molecular Structure | 1 | 2012 | 465 | 0.020 |
Why?
| | Gene Deletion | 1 | 2012 | 372 | 0.020 |
Why?
| | Diet, High-Fat | 1 | 2012 | 238 | 0.020 |
Why?
| | Cross-Sectional Studies | 1 | 2022 | 5040 | 0.020 |
Why?
| | Tumor Suppressor Protein p53 | 1 | 2014 | 507 | 0.020 |
Why?
| | Cyclic AMP-Dependent Protein Kinases | 1 | 2011 | 132 | 0.020 |
Why?
| | Diabetes Mellitus, Experimental | 1 | 2012 | 174 | 0.020 |
Why?
| | Flow Cytometry | 2 | 2006 | 1141 | 0.020 |
Why?
| | Epididymis | 1 | 2010 | 12 | 0.020 |
Why?
| | Nitric Oxide Synthase Type II | 1 | 2010 | 167 | 0.020 |
Why?
| | Macrophages, Peritoneal | 1 | 2009 | 90 | 0.020 |
Why?
| | Feces | 1 | 2012 | 432 | 0.020 |
Why?
| | Paracrine Communication | 1 | 2009 | 60 | 0.020 |
Why?
| | Stromal Cells | 1 | 2009 | 105 | 0.020 |
Why?
| | Spectrometry, Fluorescence | 1 | 2010 | 170 | 0.020 |
Why?
| | Oxygen Consumption | 2 | 2002 | 675 | 0.020 |
Why?
| | Reverse Transcriptase Polymerase Chain Reaction | 1 | 2011 | 937 | 0.020 |
Why?
| | Caspase 3 | 1 | 2010 | 229 | 0.020 |
Why?
| | Aged, 80 and over | 1 | 2021 | 7040 | 0.020 |
Why?
| | ATP Binding Cassette Transporter 1 | 1 | 2008 | 10 | 0.020 |
Why?
| | Surveys and Questionnaires | 1 | 2021 | 5346 | 0.020 |
Why?
| | Hepatocyte Nuclear Factor 4 | 1 | 2008 | 14 | 0.020 |
Why?
| | Cell Adhesion | 1 | 2009 | 444 | 0.020 |
Why?
| | Palmitates | 1 | 2007 | 18 | 0.020 |
Why?
| | Dextran Sulfate | 1 | 2008 | 76 | 0.020 |
Why?
| | ATP-Binding Cassette Transporters | 1 | 2008 | 130 | 0.020 |
Why?
| | PPAR alpha | 1 | 2007 | 59 | 0.020 |
Why?
| | Retrospective Studies | 1 | 2025 | 14460 | 0.020 |
Why?
| | Sporothrix | 1 | 2007 | 3 | 0.020 |
Why?
| | Paracoccidioides | 1 | 2007 | 2 | 0.020 |
Why?
| | Collagen | 1 | 2010 | 429 | 0.020 |
Why?
| | Pigments, Biological | 1 | 2007 | 15 | 0.020 |
Why?
| | DNA Fingerprinting | 1 | 2007 | 25 | 0.020 |
Why?
| | Blastomyces | 1 | 2007 | 8 | 0.020 |
Why?
| | Linkage Disequilibrium | 1 | 2008 | 256 | 0.020 |
Why?
| | Polymorphism, Restriction Fragment Length | 1 | 2007 | 69 | 0.020 |
Why?
| | Cell Line, Tumor | 1 | 2014 | 3160 | 0.020 |
Why?
| | DNA, Fungal | 1 | 2007 | 73 | 0.020 |
Why?
| | Gas Chromatography-Mass Spectrometry | 1 | 2007 | 126 | 0.020 |
Why?
| | Lipid Metabolism Disorders | 1 | 2006 | 2 | 0.020 |
Why?
| | Liver Glycogen | 1 | 2006 | 17 | 0.020 |
Why?
| | PPAR gamma | 1 | 2008 | 182 | 0.020 |
Why?
| | Peroxisome Proliferator-Activated Receptor Gamma Coactivator 1-alpha | 1 | 2006 | 41 | 0.020 |
Why?
| | Chromosome Mapping | 1 | 2008 | 505 | 0.020 |
Why?
| | Receptors, Leptin | 1 | 2006 | 23 | 0.020 |
Why?
| | Ventricular Function, Left | 1 | 2010 | 525 | 0.020 |
Why?
| | Receptors, Steroid | 1 | 2006 | 48 | 0.020 |
Why?
| | Haplotypes | 1 | 2008 | 471 | 0.020 |
Why?
| | Mitochondrial Membranes | 1 | 2006 | 38 | 0.020 |
Why?
| | Lipoproteins, LDL | 1 | 2006 | 126 | 0.020 |
Why?
| | Response Elements | 1 | 2006 | 89 | 0.020 |
Why?
| | Dyslipidemias | 1 | 2008 | 177 | 0.020 |
Why?
| | Octoxynol | 1 | 2005 | 13 | 0.020 |
Why?
| | Endopeptidase K | 1 | 2005 | 15 | 0.020 |
Why?
| | Immunoprecipitation | 1 | 2006 | 157 | 0.020 |
Why?
| | Sequence Deletion | 1 | 2006 | 179 | 0.020 |
Why?
| | Fluorescent Antibody Technique, Indirect | 1 | 2005 | 47 | 0.020 |
Why?
| | Oligonucleotides, Antisense | 1 | 2006 | 106 | 0.020 |
Why?
| | Extracellular Matrix | 1 | 2010 | 497 | 0.020 |
Why?
| | Acyl-CoA Oxidase | 1 | 2005 | 2 | 0.020 |
Why?
| | Ethanolaminephosphotransferase | 1 | 2005 | 1 | 0.020 |
Why?
| | Glycerol-3-Phosphate O-Acyltransferase | 1 | 2005 | 1 | 0.020 |
Why?
| | Fish Oils | 1 | 2005 | 26 | 0.020 |
Why?
| | Microarray Analysis | 1 | 2005 | 121 | 0.020 |
Why?
| | Microscopy, Confocal | 1 | 2006 | 308 | 0.010 |
Why?
| | Serine C-Palmitoyltransferase | 1 | 2004 | 6 | 0.010 |
Why?
| | Thinness | 1 | 2005 | 90 | 0.010 |
Why?
| | Serine | 1 | 2005 | 136 | 0.010 |
Why?
| | Muscle Fibers, Fast-Twitch | 1 | 2004 | 10 | 0.010 |
Why?
| | Sphingomyelins | 1 | 2004 | 29 | 0.010 |
Why?
| | Acyl Coenzyme A | 1 | 2004 | 30 | 0.010 |
Why?
| | Glycerol | 1 | 2005 | 87 | 0.010 |
Why?
| | Palmitic Acid | 1 | 2004 | 40 | 0.010 |
Why?
| | Protein Structure, Secondary | 1 | 2005 | 338 | 0.010 |
Why?
| | Catalysis | 1 | 2005 | 304 | 0.010 |
Why?
| | Homozygote | 1 | 2005 | 191 | 0.010 |
Why?
| | Receptors, Adrenergic, beta-3 | 1 | 2004 | 4 | 0.010 |
Why?
| | Echocardiography | 1 | 2007 | 625 | 0.010 |
Why?
| | Uncoupling Protein 1 | 1 | 2004 | 15 | 0.010 |
Why?
| | Fluorescence Resonance Energy Transfer | 1 | 2006 | 177 | 0.010 |
Why?
| | Plasmids | 1 | 2005 | 357 | 0.010 |
Why?
| | Cysteine | 1 | 2005 | 188 | 0.010 |
Why?
| | Endothelial Cells | 1 | 2009 | 701 | 0.010 |
Why?
| | Fats | 1 | 2004 | 14 | 0.010 |
Why?
| | 3-Hydroxybutyric Acid | 1 | 2004 | 14 | 0.010 |
Why?
| | Trans-Activators | 1 | 2006 | 381 | 0.010 |
Why?
| | Muscle Fibers, Skeletal | 1 | 2005 | 190 | 0.010 |
Why?
| | Microscopy, Fluorescence | 1 | 2005 | 402 | 0.010 |
Why?
| | Fatty Acids, Nonesterified | 1 | 2004 | 159 | 0.010 |
Why?
| | Ion Channels | 1 | 2004 | 127 | 0.010 |
Why?
| | Protein Subunits | 1 | 2004 | 231 | 0.010 |
Why?
| | Monosaccharide Transport Proteins | 1 | 2003 | 49 | 0.010 |
Why?
| | Glucose Transporter Type 4 | 1 | 2003 | 39 | 0.010 |
Why?
| | Epitopes | 1 | 2005 | 466 | 0.010 |
Why?
| | Body Temperature | 1 | 2004 | 215 | 0.010 |
Why?
| | Recombinant Fusion Proteins | 1 | 2006 | 632 | 0.010 |
Why?
| | Energy Intake | 1 | 2006 | 453 | 0.010 |
Why?
| | Polymerase Chain Reaction | 1 | 2006 | 1019 | 0.010 |
Why?
| | Transfection | 1 | 2005 | 895 | 0.010 |
Why?
| | Adult | 2 | 2021 | 35315 | 0.010 |
Why?
| | Muscles | 1 | 2004 | 323 | 0.010 |
Why?
| | Protein Conformation | 1 | 2005 | 853 | 0.010 |
Why?
| | Hydroxymethylglutaryl CoA Reductases | 1 | 2002 | 14 | 0.010 |
Why?
| | Vacuoles | 1 | 2002 | 36 | 0.010 |
Why?
| | Microsomes, Liver | 1 | 2002 | 62 | 0.010 |
Why?
| | Recombinant Proteins | 1 | 2005 | 1284 | 0.010 |
Why?
| | Crosses, Genetic | 1 | 2002 | 141 | 0.010 |
Why?
| | Cell Size | 1 | 2002 | 87 | 0.010 |
Why?
| | 3T3 Cells | 1 | 2002 | 151 | 0.010 |
Why?
| | Mitochondrial Proteins | 1 | 2004 | 238 | 0.010 |
Why?
| | Gene Dosage | 1 | 2002 | 142 | 0.010 |
Why?
| | Statistics, Nonparametric | 1 | 2002 | 423 | 0.010 |
Why?
| | Oligonucleotide Array Sequence Analysis | 1 | 2002 | 756 | 0.010 |
Why?
| | Phylogeny | 1 | 2004 | 846 | 0.010 |
Why?
| | Eating | 1 | 2002 | 365 | 0.010 |
Why?
| | Kinetics | 1 | 2002 | 1616 | 0.010 |
Why?
| | Body Mass Index | 1 | 2005 | 2262 | 0.010 |
Why?
|
|
Miyazaki's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|